Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval
Lilly plans to file by the end of the year for U.S. approval of the daily pill for moderate-to-severe obstructive sleep apnea in adults with obesity.
Markets
Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval
Fed-and-SEC desk, TradeNews USA (2026-11-09): Lilly plans to file by the end of the year for U.S. approval of the daily pill for moderate-to-severe obstructive sleep apnea in adults with obesity. Primary source: original at CNBC Top News (cnbc.com).